{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:35:23Z","timestamp":1792017323304,"version":"4.4.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Androgens have been described as important players in the regulation of vascular function\/structure through their action on the release and effect of vasoactive factors, such as prostanoids. Patients with prostate cancer (PCa) under androgen deprivation therapies (ADTs) present increased risk of cardiovascular mortality. Since thromboxane A<jats:sub>2<\/jats:sub> (TXA<jats:sub>2<\/jats:sub>) is one of the most studied prostanoids and its involvement in different cardiovascular diseases has been described, the aim of this study was to investigate: (i) the effect of ADT on the serum levels of TXA<jats:sub>2<\/jats:sub> in PCa patients and its possible link to the redox status and (ii) the effect of the non-hydrolyzable TXA<jats:sub>2<\/jats:sub> analog U-46619 on the function of the aorta of male rats.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The levels of TXA<jats:sub>2<\/jats:sub> and total antioxidant status in 50 healthy subjects, 54 PCa patients, and 57 PCa under ADT were evaluated. These determinations were accompanied by levels of testosterone and C-reactive protein as an inflammation marker. In aortic segments from male rats, the U46619-induced effects on: (i) the vasomotor responses to acetylcholine (ACh), to the NO donor sodium nitroprusside (SNP), to the carbon monoxide-releasing molecule-3 (CORM-3), and to noradrenaline (NA) and (ii) the expression of cyclooxygenase-2 (COX-2), heme oxygenase-1 (HO-1), and phosphorylated ERK1\/2 were analyzed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The serum level of TXA<jats:sub>2<\/jats:sub> in patients with PCa was increased with respect to healthy subjects, which was further increased by ADT. There was no modification in the total antioxidant status among the three experimental groups. In aortic segments from male rats, the TXA<jats:sub>2<\/jats:sub> analog decreased the endothelium-dependent relaxation and the sensitivity of smooth muscle cells to NO, while it increased the vasoconstriction induced by NA; the expression of COX-2, HO-1, and pERK1\/2 was also increased.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> ADT increased, along with other inflammatory\/oxidative markers, the serum levels of TXA<jats:sub>2<\/jats:sub>. The fact that TXA<jats:sub>2<\/jats:sub> negatively impacts the vascular function of the aorta of healthy male rats suggests that inhibition of TXA<jats:sub>2<\/jats:sub>-mediated events could be considered a potential strategy to protect the cardiovascular system.<\/jats:p>","DOI":"10.3389\/fcvm.2021.653126","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:13:36Z","timestamp":1618294416000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Androgen Deprivation Therapy in Patients With Prostate Cancer Increases Serum Levels of Thromboxane A2: Cardiovascular Implications"],"prefix":"10.3389","volume":"8","author":[{"given":"Mario","family":"\u00c1lvarez-Maestro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aritz","family":"Eguibar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Chanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Klett-Mingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"G\u00f3mez Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bu\u00f1o-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferm\u00edn R.","family":"de Bethencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pros.23923","article-title":"Disparities in prostate cancer incidence and mortality rates: solvable or not?","volume":"80","author":"Badal","year":"2020","journal-title":"Prostate."},{"key":"B2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2019.04.033","article-title":"Structured population-based prostate-specific antigen screening for prostate cancer: The European association of urology position in 2019","volume":"76","author":"Gandaglia","year":"2019","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/pcan.2016.69","article-title":"Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update","volume":"20","author":"Owen","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11936-017-0563-1","article-title":"Cardiovascular complications of androgen deprivation therapy for prostate cancer","volume":"19","author":"Gupta","year":"2017","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/JOE-12-0582","article-title":"Testosterone: a vascular hormone in health and disease","volume":"217","author":"Kelly","year":"2013","journal-title":"J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.juro.2012.11.017","article-title":"Metabolic complications of androgen deprivation therapy for prostate cancer","volume":"189","author":"Saylor","year":"2013","journal-title":"J Urol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.14310\/horm.2002.1727","article-title":"Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications","volume":"16","author":"Tzortzis","year":"2017","journal-title":"Hormones"},{"key":"B8","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.eururo.2014.11.039","article-title":"Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis","volume":"68","author":"Bosco","year":"2015","journal-title":"Eur Urol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.eururo.2013.03.055","article-title":"Locally advanced and metastatic prostate cancer treated with intermittent androgen monotherapy or maximal androgen blockade: results from a randomised phase 3 study by the South European Uroncological Group","volume":"66","author":"da Silva","year":"2014","journal-title":"Eur Urol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e107516","DOI":"10.1371\/journal.pone.0107516","article-title":"Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS ONE"},{"key":"B11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/01.CIR.78.3.539","article-title":"Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study","volume":"78","author":"Barrett-Connor","year":"1988","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00004872-199307000-00003","article-title":"Sex. hormones and hemostatic risk factors for coronary heart disease in men with hypertension","volume":"11","author":"Phillips","year":"1993"},{"key":"B13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1210\/jc.82.2.682","article-title":"Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: the Telecom Study","volume":"82","author":"Simon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1530\/eje.0.1500065","article-title":"Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Troms\u00f8 Study","volume":"150","author":"Svartberg","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/VHRM.S108947","article-title":"Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study","volume":"12","author":"Haider","year":"2016","journal-title":"Vasc Health Risk Manag"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0142039","DOI":"10.1371\/journal.pone.0142039","article-title":"Effect of dietary docosahexaenoic acid supplementation on the participation of vasodilator factors in aorta from orchidectomized rats","volume":"10","author":"Villalpando","year":"2015","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1677\/joe.1.06887","article-title":"Orchidectomy increases expression and activity of Cu\/Zn-superoxide dismutase, while decreasing endothelial nitric oxide bioavailability","volume":"190","author":"Blanco-Rivero","year":"2006","journal-title":"J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000089791","article-title":"Orchidectomy modulates alpha2-adrenoceptor reactivity in rat mesenteric artery through increased thromboxane A2 formation","volume":"43","author":"Blanco-Rivero","year":"2006","journal-title":"J Vasc Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/cvr\/cvm059","article-title":"Orchidectomy increases the formation of prostanoids and modulates their role in the acetylcholine-induced relaxation in the rat aorta","volume":"77","author":"Martorell","year":"2008","journal-title":"Cardiovasc Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1042\/CS20120700","article-title":"Testosterone and \u03b2-oestradiol prevent inward remodelling of rat small mesenteric arteries: role of NO and transglutaminase","volume":"124","author":"del Campo","year":"2013","journal-title":"Clin Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e102523","DOI":"10.1371\/journal.pone.0102523","article-title":"Time-dependent effect of orchidectomy on vascular nitric oxide and thromboxane A2 release. Functional implications to control cell proliferation through activation of the epidermal growth factor receptor","volume":"9","author":"del Campo","year":"2014","journal-title":"PLoS ONE."},{"key":"B22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1124\/jpet.108.144295","article-title":"Hypertension increases contractile responses to hydrogen peroxide in resistance arteries through increased thromboxane A2, Ca2+, and superoxide anion levels","volume":"328","author":"Garc\u00eda-Redondo","year":"2009","journal-title":"J Pharmacol Exp Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.prostaglandins.2017.11.004","article-title":"Role of thromboxane A2 signaling in endothelium-dependent contractions of arteries","volume":"134","author":"Chen","year":"2018","journal-title":"Prostaglandins and Other Lipid Mediators"},{"key":"B24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"38757","DOI":"10.1038\/srep38757","article-title":"Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor","volume":"6","author":"Cong","year":"2016","journal-title":"Sci Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1677\/JOE-07-0647","article-title":"Orchidectomy increases the formation of non-endothelial thromboxane A2 and modulates its role in the electrical field stimulation-induced response in rat mesenteric artery","volume":"197","author":"del Campo","year":"2008","journal-title":"J Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1196\/annals.1378.053","article-title":"Role of reactive oxygen species in Kv channel inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteries","volume":"1091","author":"Cogolludo","year":"2006","journal-title":"Ann N Y Acad Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.plefa.2008.01.008","article-title":"Acute inhibition of superoxide formation and Rac1 activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane A2 analogue, U46619","volume":"78","author":"Muzaffar","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"key":"B29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-1-4419-9194-2_14","article-title":"Thromboxane-induced ERK phosphorylation in human aortic smooth muscle cells","volume":"525","author":"Gallet","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0006-8993(71)90370-2","article-title":"Contractile response and amine receptor mechanisms in isolated middle cerebral artery of the cat","volume":"27","author":"Nielsen","year":"1971","journal-title":"Brain Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbadis.2017.01.011","article-title":"Regulation of protein kinase C-related kinase (PRK) signalling by the TPalpha and TPbeta isoforms of the human thromboxane A(2) receptor: Implications for thromboxane- and androgen- dependent neoplastic and epigenetic responses in prostate cancer","volume":"1863","author":"O'Sullivan","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10555-011-9297-9","article-title":"The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis","volume":"30","author":"Ekambaram","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.eururo.2006.01.036","article-title":"Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor gleason score and pathologic stage","volume":"50","author":"Dassesse","year":"2006","journal-title":"Eur Urol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1097\/01.ju.0000142058.99614.ff","article-title":"The role of inflammation in the pathogenesis of prostate cancer","volume":"172","author":"Nelson","year":"2004","journal-title":"J Urol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ebiom.2014.12.004","article-title":"Circulating prostaglandin biosynthesis in colorectal cancer and potential clinical significance","volume":"2","author":"Li","year":"2015","journal-title":"EBioMed"},{"key":"B36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wan","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s00345-019-03054-5","article-title":"Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau)","volume":"38","author":"Prause","year":"2020","journal-title":"World J Urol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2004325","article-title":"Oral relugolix for androgen-deprivation therapy in advanced prostate cancer","volume":"382","author":"Shore","year":"2020","journal-title":"N Engl J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/13685530701653538","article-title":"Effect of androgen deprivation on glycaemic control and on cardiovascular risk factors in men with advanced prostate cancer with diabetes","volume":"10","author":"Haidar","year":"2007","journal-title":"Aging Male"},{"key":"B40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1476-511X-10-82","article-title":"Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndrome","volume":"10","author":"Novgorodtseva","year":"2011","journal-title":"Lipids Health Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/HYPERTENSIONAHA.111.188730","article-title":"Reduced methylation of the thromboxane synthase gene is correlated with its increased vascular expression in preeclampsia","volume":"59","author":"Mousa","year":"2012","journal-title":"Hypertension."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1073\/pnas.85.12.4511","article-title":"Increased prostacyclin andthromboxane A2 biosynthesis in atherosclerosis","volume":"85","author":"Mehta","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"B43","first-page":"207","article-title":"Regulation of atrial natriuretic peptide, thromboxane and prostaglandin production by androgen in elderly men with coronary heart disease","volume":"8","author":"Wu","year":"1993","journal-title":"Chin Med Sci J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"106406","DOI":"10.1016\/j.prostaglandins.2019.106406","article-title":"Gonadal function protects against organ culture-induced vascular damage. involvement of prostanoids","volume":"148","author":"Villalpando","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B45","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/molecules23040983","article-title":"Plasma and salivary non-urate total antioxidant capacity does not depend on dietary vitamin C, E, or \u03b2-carotene intake in older subjects","volume":"23","author":"Gawron-Skarbek","year":"2018","journal-title":"Molecules"},{"key":"B46","doi-asserted-by":"publisher","first-page":"OC27","DOI":"10.7860\/JCDR\/2016\/16335.7281","article-title":"Uric acid and coronary artery disease, two sides of a single coin: a determinant of antioxidant system or a factor in metabolic syndrome","volume":"10","author":"Bagheri","year":"2016","journal-title":"J Clin Diagn Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0021-9150(99)00214-2","article-title":"Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?","volume":"148","author":"Nieto","year":"2000","journal-title":"Atherosclerosis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e73474","DOI":"10.1371\/journal.pone.0073474","article-title":"Ovariectomy increases the participation of hyperpolarizing mechanisms in the relaxation of rat aorta","volume":"8","author":"Sagredo","year":"2013","journal-title":"PLoS ONE"},{"key":"B49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/HJH.0000000000000383","article-title":"c-Src, ERK1\/2 and Rho kinase mediate hydrogen peroxide-induced vascular contraction in hypertension: r ole of TXA2, NAD(P)H oxidase and mitochondria","volume":"33","author":"Garc\u00eda-Redondo","year":"2015","journal-title":"J Hypertens."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/j.athoracsur.2006.01.024","article-title":"Thromboxane receptor stimulation suppresses guanylate cyclase-mediated relaxation of radial arteries","volume":"81","author":"Arshad","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"B51","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/368850a0","article-title":"Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle","volume":"368","author":"Bolotina","year":"1994","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0306-3623(98)00259-6","article-title":"Role of K+ channels and sodium pump in the vasodilation induced by acetylcholine, nitric oxide, and cyclic GMP in the rabbit aorta","volume":"33","author":"Ferrer","year":"1999","journal-title":"Gen Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"H1402","DOI":"10.1152\/ajpheart.00882.2014","article-title":"Induction and functional significance of the heme oxygenase system in pathological shear stress in vivo","volume":"308","author":"Kang","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"108073","DOI":"10.1016\/j.abb.2019.108073","article-title":"HO-1 overexpression and underexpression: clinical implications","volume":"673","author":"Drummond","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"B55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.cardiores.2005.07.013","article-title":"Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism","volume":"69","author":"Eligini","year":"2006","journal-title":"Cardiovasc Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"9309","DOI":"10.1016\/S0021-9258(18)31586-2","article-title":"The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family","volume":"266","author":"Shenker","year":"1991","journal-title":"J Biol Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/sj.bjp.0706398","article-title":"Role of the PKC\/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to alpha-adrenoceptor stimulation","volume":"146","author":"Mueed","year":"2005","journal-title":"Br J Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0008-6363(01)00390-X","article-title":"U-46619-induced potentiation of noradrenergic constriction in the human saphenous vein: antagonism by thromboxane receptor blockade","volume":"52","author":"Vila","year":"2001","journal-title":"Cardiovasc Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.urolonc.2019.02.010","article-title":"Androgen deprivation therapy and cardiovascular disease","volume":"38","author":"Melloni","year":"2020","journal-title":"Urol Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41391-018-0059-4","article-title":"Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: a systematic review and meta-analysis","volume":"21","author":"Guo","year":"2018","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.urology.2017.11.055","article-title":"Association of androgen deprivation therapy and thromboembolic events: a systematic review and meta-analysis","volume":"114","author":"Nead","year":"2018","journal-title":"Urology"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.653126\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:13:40Z","timestamp":1618294420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.653126\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":61,"alternative-id":["10.3389\/fcvm.2021.653126"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.653126","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"article-number":"653126"}}